Palatin Technologies, Inc.

AMEX:PTN

Biotechnology

Healthcare
$9.09 -0.82%

-$0.10 today

Market cap
$236.39M
Beta
0.94
P/E (TTM)
-1.9
EPS (TTM)
-$6.43
52W Low $5.00High $31.00

Volume 0.02M

Average 1.78M

PTN Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Palatin Technologies, Inc.AMEX: PTN

Accounts Payables · Q3 FY2026 · quarter ended Mar 2026

Accounts payables turns negative

Q3 FY2026 accounts payables was -$8.56K, compared with $1.05M a year earlier. Trailing-twelve-month accounts payables was -$2.33M. Over 3 fiscal years it compounded at +4.0% a year.

Context

  • Accounts payables increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts payables holds near -$8.56K or moves back toward the trailing-twelve-month quarterly average of -$581.51K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$8.56K-99.6% QoQ
Last fiscal yearJun 2025
$2.9M+1537.0% YoY
LTMMar 2026
-$2.33M-153.8% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.8%——
1 year+1537.0%——
3-year CAGR+4.0%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
2.9M USD
Year-over-year change
+1537.0%

Accounts Payables vs competitors

How PTN compares with its peers on the latest reported figures

  • PTN's LTM Mar 2026 accounts payables of $2.33M is the largest of the 2 companies compared; the peer median is $2.06M.
  • Its year-over-year change of -153.8% is the lowest of 2, against a peer median of -8.4%.
  • Accounts payables amounts to 18.1% of revenue for PTN, versus a peer median of 3.8%.
PTN Competitors Peer median
Accounts Payables for PTN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PTNPalatin Technologies, Inc.LTM Mar 2026$2.33M -153.8%+4.0%18.1%
QTTBQ32 Bio Inc.LTM Mar 2026$2.06M -8.4%+19.4%3.8%
Peer median (excluding PTN) $2.06M-8.4%+19.4%3.8%

Competitors are the stored peer set for PTN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Net Income(33.6M)(36.2M)(27.54M)(29.74M)(17.31M)
Depreciation & Amortization51.12K126.67K288.33K339.08K258.92K
Deferred Income Tax212.53K0(392.27K)00
Stock-Based Compensation3.17M2.51M1.41M1.87M1.38M
Change in Working Capital(11.9M)3.44M(2.35M)(3.41M)(758.79K)
Accounts Receivables(1.58M)(199.58K)(1.14M)2.92M(29.47K)
Inventory(987.24K)217.53K418.47K(1.15M)0
Accounts Payables(75.02K)2.57M1.11M(201.6K)2.9M
Other Working Capital(9.26M)848.81K(2.74M)(4.97M)(3.63M)
Other Non-Cash Items19.42M203.92K166.26K(530.26K)(4.88M)
Operating Cash Flow(22.65M)(29.92M)(28.42M)(31.46M)(21.31M)
Capital Expenditures(5.72K)(261.37K)(433.93K)(42.53K)(3)
Acquisitions (Net)0009.5M3.13M
Purchases of Investments00(2.99M)00
Sales of Investments0002.99M0
Other Investing Activities00000
Investing Cash Flow(5.72K)(261.37K)(3.43M)12.45M3.13M
Debt Repayment0(56.46K)(100.92K)(106.39K)(46.01K)
Common Stock Issued0010.14M14.67M7.96M
Common Stock Repurchased(93.64K)(221.31K)000
Dividends Paid00000
Other Financing Activities0296.13K(145.98K)5.99M3.3M
Financing Cash Flow(93.64K)18.36K9.9M20.55M11.21M
Effect of Forex Changes00000
Net Change in Cash(22.75M)(30.17M)(21.95M)1.54M(6.96M)
Free Cash Flow(22.65M)(30.18M)(28.85M)(31.5M)(21.31M)

Palatin Technologies, Inc.

AMEX:PTN

Intrinsic Alpha fair value

Locked

Current Price

$9.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.